October 13, 2026

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling a 24% Potential Upside in Biotech Innovation

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is capturing investor attention with its innovative approach to biotechnology and a promising potential upside. As a clinical-stage biopharmaceutical company, Kymera focuses on developing small..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating its 12.32% Upside Potential Amidst Challenging Metrics

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the medical care facilities sector, is drawing significant attention from investors due to its recent stock performance and the potential..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 32% Potential Upside for Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector, is drawing attention with its potential for a 32.15% upside, according to recent analyst ratings. As a key..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 64.59% Potential Upside in the Biotechnology Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands as a formidable player in the biotechnology sector, specializing in innovative treatments for neurological and rare diseases. With a market capitalization of $3.32 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Biotech Giant Eyes 34.77% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biopharmaceutical sector, is making waves with its promising growth potential, despite recent challenges in the biotech industry. With a market..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating a Stable Path with a $10.22 Billion Market Cap

Apogee Therapeutics, Inc. (NASDAQ: APGE), a dynamic player in the biotechnology sector, is making waves with its innovative approach to treating immunological and inflammatory diseases. Despite its brief operational history..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unpacking a 13.4% Upside Potential

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry. With a market capitalization of $6.98..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a 32.70% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (VCYT), a notable player in the healthcare sector, stands as a promising entity within the diagnostics and research industry. With a market capitalization of $3.54 billion, this U.S.-based..

Envista Holdings Corporation (NVST) Stock Report: Exploring a Potential 30% Upside

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in medical instruments and supplies, focusing primarily on dental products. Headquartered in Brea, California, Envista operates globally,..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring the 60.63% Potential Upside

For investors seeking opportunities in the biotechnology sector, PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling case with a robust potential upside of 60.63%, based on the average analyst target..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Potential 82% Upside with Strong Buy Ratings

Alignment Healthcare, Inc. (NYSE: ALHC) offers a compelling opportunity for investors seeking exposure to the fast-growing healthcare sector, particularly in the niche of senior-focused Medicare Advantage plans. Despite a challenging..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating Its 55% Potential Upside

Investors eyeing opportunities in the healthcare sector may want to take a closer look at DENTSPLY SIRONA Inc. (NASDAQ: XRAY). Despite recent challenges, the company presents a compelling case for..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook on a Promising 75% Potential Upside in Gene Therapy

For investors navigating the dynamic world of biotechnology, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling case. With its focus on developing treatments for rare and ultra-rare genetic diseases, Ultragenyx..

Perrigo Company plc (PRGO) Stock Analysis: Navigating Healthcare with a 7.51% Dividend Yield

For individual investors eyeing a unique blend of stability and potential, Perrigo Company plc (PRGO) presents an intriguing opportunity in the healthcare sector. Headquartered in Dublin, Ireland, Perrigo operates within..

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

Drax Group shares offer 47% potential upside according to Longspur Research, with data centre ambitions remaining attractive...

Low market volatility could be masking underlying risks | Ruffer Investment Company

Ruffer's Nicole Wardle explains why record-low stock correlations could be masking US equity market risks, while creating opportunities in overlooked shares and defensive volatility protection...

Physitrack to publish Q3 2026 results on 20 October

Physitrack PLC will publish its Q3 2026 interim report on 20 October 2026 at 08:00 CET, followed by a webcast at 18:00 CET featuring CEO Henrik Molin and CFO Matt..

Bytes Technology Group upgrades guidance after 18% revenue growth

Bytes Technology Group reported an 18.7% increase in first-half revenue to £128.3m, with gross profit up 17.8% to £97.1m. The group upgraded its full-year guidance in September and expects continued..

Balfour Beatty sells Gammon Construction stake for £250m

Balfour Beatty has sold its 50% stake in Hong Kong-based Gammon Construction to joint venture partner Jardine Matheson for £250m, supporting its focus on core UK and US markets. The..

Whitbread Reports Strong Hotel Sales Growth and Reaffirms FY27 Outlook

Whitbread reported 3% growth in UK and Ireland accommodation sales and double-digit growth in Germany, with adjusted profit before tax falling to £287m. The group remains confident in its full-year..
Search

Funds

October 13, 2026

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

Drax Group shares offer 47% potential upside according to Longspur Research, with data centre ambitions remaining attractive...

Low market volatility could be masking underlying risks | Ruffer Investment Company

Ruffer's Nicole Wardle explains why record-low stock correlations could be masking US equity market risks, while creating opportunities in overlooked shares and defensive volatility protection...

Physitrack to publish Q3 2026 results on 20 October

Physitrack PLC will publish its Q3 2026 interim report on 20 October 2026 at 08:00 CET, followed by a webcast at 18:00 CET featuring CEO Henrik Molin and CFO Matt Poulter. Investors will be able to submit questions through Zoom’s Q&A function...

Bytes Technology Group upgrades guidance after 18% revenue growth

Bytes Technology Group reported an 18.7% increase in first-half revenue to £128.3m, with gross profit up 17.8% to £97.1m. The group upgraded its full-year guidance in September and expects continued growth, supp..

Balfour Beatty sells Gammon Construction stake for £250m

Balfour Beatty has sold its 50% stake in Hong Kong-based Gammon Construction to joint venture partner Jardine Matheson for £250m, supporting its focus on core UK and US markets. The proceeds will be received in three equal tranches, with the first £83.3m payable on completion...

Whitbread Reports Strong Hotel Sales Growth and Reaffirms FY27 Outlook

Whitbread reported 3% growth in UK and Ireland accommodation sales and double-digit growth in Germany, with adjusted profit before tax falling to £287m. The group remains confident in its full-year outlook and targets £2bn for shareholder returns by FY31...
Search

Funds

October 13, 2026

FTSE 100

Funds